P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As2O3), but are not the main mechanism of As2O3-resistance in acute promyelocytic leukemia cells

This publication has 7 references indexed in Scilit:

• Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers
  Leukemia, 2002
• Role of the Multidrug Resistance Protein 1 in Protection from Heavy Metal Oxyanions: Investigations in Vitro and in MRP1-Deficient Mice
  Biochemical and Biophysical Research Communications, 2002
• Overexpression of GlutathioneS-Transferase II and Multidrug Resistance Transport Proteins Is Associated with Acquired Tolerance to Inorganic Arsenic
  Molecular Pharmacology, 2001
• Effects of arsenic trioxide (As₂O₃) on leukemic cells from patients with non‐M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance
  European Journal of Haematology, 2001
• Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis
  Leukemia, 2000
• Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-xL
  Blood, 2000
• Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA
  British Journal of Haematology, 2000